PHAT - Phathom Pharmaceuticals, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$23.00
DETAILS
HIGH:
$28.00
LOW:
$18.00
MEDIAN:
$23.00
CONSENSUS:
$23.00
UPSIDE:
89.14%
Profitability Ratios
| Ratio | Value |
|---|---|
| GP Margin | 87.1% |
| EBIT Margin | -87.4% |
| EBITDA Margin | -87.1% |
| Operating Margin | -91.4% |
| Pretax Margin | -126.3% |
| Cont. Ops Margin | -126.3% |
| Net Margin | -126.3% |
| Bottom Line Margin | -126.3% |
Liquidity Ratios
| Ratio | Value |
|---|---|
| Current Ratio | 1.73 |
| Quick Ratio | 1.69 |
| Solvency Ratio | -0.316 |
| Cash Ratio | 0.98 |
Valuation Ratios
| Ratio | Value |
|---|---|
| Price/Earnings |
-5.48
Peers avg: 32.2
|
| PEG Ratio | 0.13 |
| Forward PEG | 0.13 |
| Price/Book | -2.76 |
| Price/Sales | 6.91 |
| Price/FCF | -7.25 |
| Price/Op Cash Flow | -7.25 |
Debt Ratios
| Ratio | Value |
|---|---|
| Debt/Assets | 0.8173 |
| Debt/Equity | -0.4834 |
| Debt/Capital | -0.9356 |
| Long-Term Debt/Capital | -0.9127 |
| Financial Leverage | -0.59 |
Cash Flow Ratios
| Ratio | Value |
|---|---|
| Working Capital Turnover | 0.94 |
| Operating Cash Flow Ratio | -1.263 |
| Operating Cash Flow/Sales | -95.2% |
| Free Cash Flow/Operating Cash Flow | 100.0% |
Coverage Ratios
| Ratio | Value |
|---|---|
| Debt Service Coverage | -2.22 |
| Interest Coverage | -2.3488 |
| Short-Term Operating Cash Flow Coverage | -257.37 |
| Operating Cash Flow Coverage | -0.79 |
| Capital Expenditure Coverage | -728.28 |
| Dividend + Capital Expenditure Coverage | -728.28 |
Dividend Ratios
| Ratio | Value |
|---|---|
| Payout Ratio | 0.0000% |
| Dividend Yield | 0.0000% |
| Dividend Yield % | 0.0000% |
| Dividend Per Share | 0.0000 |
Per Share Ratios
| Ratio | Value |
|---|---|
| Revenue/Share | 2.40 |
| EPS | -3.034 |
| Debt/Share | 3.8387 |
| Cash/Share | 1.78 |
| Book Value/Share | -6.01 |
| Tangible BV/Share | -6.01 |
| Equity/Share | -6.01 |
| Operating Cash Flow/Share | -2.287 |
| Capital Expenditure/Share | 0.003 |
| FCF/Share | -2.287 |
Other Ratios
| Ratio | Value |
|---|---|
| Net Income/Earnings Before Tax | 1.000 |
| Earnings Before Tax/EBIT | 1.383 |
| Price/Fair Value | -2.76 |
| Debt/Market Cap | 0.1734 |
| Effective Tax Rate | 0.0% |
| Enterprise Value Multiple | -8.47 |